All Guides
Depression Care · Quick Read
5 Signs You Might Have Treatment-Resistant Depression (And Why That Label Is Actually Empowering)
"Treatment-resistant" sounds intimidating—until you realize it is the exact clinical key that unlocks insurance-covered TMS and SPRAVATO®.
Modal Mental HealthPublished · Updated 4 min read
It is a clinical threshold, not a life sentence
If you have been told—or suspect—you have Treatment-Resistant Depression (TRD), take a breath. Clinically, TRD simply means your depression has not fully responded to two or more standard antidepressants.
Far from being bad news, meeting TRD criteria is what unlocks insurance coverage for evidence-based interventional treatments like TMS and SPRAVATO®.
5 signs it is time for a new approach
Consider scheduling a psychiatric evaluation—in person or via New York Virtual Care—if you recognize any of these patterns:
- 1. You have tried two or more antidepressants at full doses for 6–8+ weeks without lasting relief.
- 2. Your medication took the sharpest edge off, but you still feel flat, exhausted, or unable to enjoy life.
- 3. Side effects—weight gain, brain fog, or fatigue—keep forcing you to quit medications early.
- 4. Talk therapy helps you cope, yet the biological heaviness of depression refuses to budge.
- 5. Every medication change feels like starting the 2-month waiting clock all over again.
Common Questions
Intolerance to medications often counts alongside lack of efficacy when insurers review prior trials for TMS or SPRAVATO®. Our team reviews your full medication history during your benefits check.
More Patient Guides
All guidesDepression Care
Treatment-Resistant Depression: Comparing TMS, SPRAVATO®, and Medication Care
6 min readRead
Depression Care
TMS vs. SPRAVATO® in 60 Seconds: How Real Patients Choose
3 min readRead
Depression Care
What STAR*D Taught Us About Sequenced Antidepressant Trials—and When to Pivot to Interventional Psychiatry
7 min readRead